Good afternoon and welcome. We are pleased to welcome you today.
Ms. Mehra, I would like to go back to your comments about drug costs. Given that there is an agreement that protects intellectual property, do you not see an opportunity for Canadians to do research to develop drugs to treat diseases that are found primarily in Canada, such as multiple sclerosis? Sometimes, research is so expensive that pharmaceutical companies do not see the importance of investing or of doing research. What is your view on that?